Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

Neuroscience and Biobehavioral Reviews

Volumn 30, Issue 1, 2006, Pages 1-23

  Cools, Roshan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive flexibility; Dopamine; Dorsal striatum; L DOPA; Learning; Parkinson's disease; Prefrontal cortex; Reward; Stability; Ventral striatum

Indexed keywords

DOPAMINE; LEVODOPA; PERGOLIDE;

CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONCENTRATION RESPONSE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DRUG DEPENDENCE; DRUG EFFECT; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; TASK PERFORMANCE; WITHDRAWAL SYNDROME; WORKING MEMORY;

ANIMALS; ANTIPARKINSON AGENTS; COGNITION; DOPAMINE; HUMANS; LEVODOPA; NEURONAL PLASTICITY; PARKINSON DISEASE;

EID: 28844448732     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2005.03.024     Document Type: Review

References (247)

1. E. Abercrombie, A. Bonatz, and M. Zigmond Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats Brain Res. 525 1990 36 44
2. Y. Agid, M. Ruberg, B. Dubois, and B. Pillon Anatomoclinical and biochemical concepts of subcortical dementia S.M. Stahl S.D. Iversen E.C. Goodman Cognitive Neurochemistry 1987 Oxford University Press Oxford 248 271
3. G. Alexander, M. DeLong, and P. Stuck Parallel organisation of functionally segregated circuits linking basal ganglia and cortex Annu. Rev. Neurosci. 9 1986 357 381
4. L. Annett, A. McGregor, and T. Robbins The effects of ibutenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat Behav. Brain Res. 31 1989 231 242
5. A.F.T. Arnsten Catecholamine modulation of prefrontal cortical cognitive function Trends Cogn. Sci. 2 1998 436 446
6. G. Batholini, M. Da Prada, and A. Pletscher Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase J. Pharm. Pharmacol. 20 1968 228 229
7. W.W. Beatty, and N. Monson Problem solving in Parkinson's disease: comparison of performance on the Wisconsin and California card sorting tests J. Geriatr. Psychiatr. Neurol. 3 1990 163 171
8. A. Bechara, S. Dolan, and A. Hindes Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 40 2002 1690 1705
9. P. Bedard, B. Mancilla, P. Blanchette, C. Gagnon, and T. Di Paolo Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? Can. J. Neurol. Sci. 19 1992 134 137
10. M.-A. Bedard, F. El Massioui, C. Malapani, B. Dubois, B. Pillon, B. Renault, and Y. Agid Attentional deficits in Parkinson's disease: partial reversibility with Naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist Clin. Neuropharmacol. 21 1998 108 177
11. 123I-FP-CIT SPECT study Neuropsychologia 42 2004 1071 1078
12. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J. Neurol. Sci. 20 1973 415 455
13. R. Bilder, K. Volavka, H. Lachman, and A. Grace The catechol-O- methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes Neuropsychopharmacol., Adv. Online Publn 2004 1 19
14. R. Bordet, S. Ridray, S. Carboni, J. Diaz, P. Sokoloff, and J. Schwartz Free in PMC induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa Proc. Natl Acad. Sci. USA 94 1997 3363 3367
15. F.P. Bowen, R.S. Kamienny, M.M. Burns, and M.D. Yahr Parkinsonism: effects of levodopa treatment on concept formation Neurology 25 1975 701 704
16. V. Bradley, J. Welch, and D. Dick Visuospatial working memory in Parkinson's disease J. Neurol. Neurosurg. Psychiatry 52 1989 1228 1235
17. M. Brass, H. Ruge, N. Meiran, O. Rubin, I. Koch, S. Zysset, W. Prinz, and D.Y. von Cramon When the same response has different meaning: recoding the response meaning in the lateral prefrontal cortex NeuroImage 20 2003 1026 1031
18. T.S. Braver, and J.D. Cohen On the control of control: the role of dopamine in regulating prefrontal function and working memory S. Monsell J. Driver Control of Cognitive Processes. Attention and Performance XVIII 2000 The MIT Press Cambridge, MA 713 737
19. D. Brooks PET studies on the function of dopamine in health and Parkinson's disease Ann. NY Acad. Sci. 991 2003 22 35
20. J. Brown, and T. Braver Learned predictions of error likelihood in the anterior cingulate cortex Science 307 2005 1118 1121
21. R. Brown, and C. Marsden How common is dementia in Parkinson's disease Lancet 2 1984 1262 1265
22. R. Brown, and C. Marsden 'Subcortical dementia': the neuropsychological evidence Neuroscience 25 1988 363 387
23. R.G. Brown, and C.D. Marsden Internal versus external cues and the control of attention in Parkinson's disease Brain 111 1988 323 345
24. R.G. Brown, and C.D. Marsden An investigation of the phenomenon of 'set' in Parkinson's disease Mov. Disord. 3 1988 152 161
25. A. Bruck, R. Portin, A. Lindell, A. Laihinen, J. Bergman, M. Haaparanta, O. Solin, and J. Rinne Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus Neurosci. Lett. 311 2001 81 84
26. E. Buytenhuijs, H. Berger, K. Van Spaendonck, M. Horstink, G. Borm, and A. Cools Memory and learning strategies in patients with Parkinson's disease Neuropsychologia 32 1994 335 342
27. M. Cador, J. Taylor, and T. Robbins Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens Psychopharmacology 104 1991 377 385
28. C. Caltarigone, A. Carlesimo, U. Nocentini, and S. Vicari Defective concept formation in parkinsonism is independent from mental deterioration J. Neurol. Neurosurg. Psychiatry 52 1989 334 337
29. M. Camps, P. Kelly, and J. Palacios Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species J. Neural. Transm. Gen. Sect. 80 1990 105 127
30. A.G.M. Canavan, R.E. Passingham, C.D. Marsden, N. Quinn, M. Wyke, and C.E. Polkey The performance on learning tasks of patients in the early stages of Parkinson's disease Neuropsychologia 27 1989 141 156
31. M. Carbon, and R.-M. Marie Functional imaging of cognition in Parkinson's disease Curr. Opin. Neurobiol. 2003 16
32. R. Cardinal, J. Parkinson, J. Hall, and B. Everitt Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex Neurosci. Biobehav. Rev. 26 2002 321 352
33. R. Carey, H. Dai, J. Huston, M. Pinheiro-Carrera, R. Schwarting, and C. Tomaz L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism Brain Res. Bull. 37 1995 295 299
34. D. Charbonneau, R. Riopelle, and R. Beninger Impaired incentive learning in treated Parkinson's disease Can. J. Neurol. Sci. 23 1996 271 278
35. H. Clarke, J. Dalley, H. Crofts, T. Robbins, and A. Roberts Cognitive inflexibility after prefrontal serotonin depletion Science 304 2004 878 880
36. J. Cohen, T. Braver, and J. Brown Computational perspectives in dopamine function in prefrontal cortex Curr. Opin. Neurobiol. 12 2002 223 229
37. P. Collins, A.C. Roberts, R. Dias, B.J. Everitt, and T.W. Robbins Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex J. Cogn. Neurosci. 10 1998 332 354
38. P. Collins, L.S. Wilkinson, B.J. Everitt, T.W. Robbins, and A.C. Roberts The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function Behav. Neurosci. 114 2000 3 17
39. A.R. Cools, J.H.L. Van Den Bercken, M.W.I. Horstink, K.P.M. Van Spaendonck, and H.J.C. Berger Cognitive and motor shifting aptitude disorder in Parkinson's disease J. Neurol. Neurosurg. Psychiatry 47 1984 443 453
40. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands Cerebral Cortex 11 2001 1136 1143
41. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins Mechanisms of cognitive set flexibility in Parkinson's disease Brain 124 2001 2503 2512
42. R. Cools, L. Clark, A.M. Owen, and T.W. Robbins Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging J. Neurosci. 22 2002 4563 4567
43. R. Cools, E. Stefanova, R.A. Barker, T.W. Robbins, and A.M. Owen Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET Brain 125 2002 584 594
44. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease Neuropsychologia 41 11 2003 1431 1441
45. R. Cools, L. Clark, and T. Robbins Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance J. Neurosci. 24 2004 1129 1135
46. Cools, R., Lewis, S., Clark, L., Barker, R., Robbins, T., 2005. L-Dopa in Parkinson's disease abolishes nucleus accumbens activation during probabilistic reversal learning. Cognitive Neuroscience Annual Meeting, New York.
47. J.A. Cooper, H.J. Sagar, N. Jordan, N.S. Harvey, and E.V. Sullivan Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability Brain 114 1991 2095 2122
48. J.A. Cooper, H.J. Sagar, S.M. Doherty, N. Jordan, P. Tidswell, and E.V. Sullivan Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease Brain 115 1992 1701 1725
49. A. Costa, A. Peppe, G. Dell'Agnello, G. Carlesimo, L. Murri, U. Bonuccelli, and C. Caltarigone Dopaminergic modulation of visual-spatial working memory in Parkinson's disease Dem. Geriatr. Cogn. Disord. 15 2003 55 66
50. J. Coull Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition Drugs Aging 5 1994 116 126
51. H.S. Crofts, J.W. Dalley, J.C.M. Van Denderen, B.J. Everitt, T.W. Robbins, and A.C. Roberts Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set Cerebral Cortex 11 2001 1015 1026
52. C. Curtis, and M. D'Esposito Persistent activity in the prefrontal cortex during working memory Trends Cogn. Sci. 7 2003 415 423
53. V. Czernecki, B. Pillon, J.L. Houeto, J.B. Pochon, R. Levy, and B. Dubois Motivation, reward and Parkinson's disease Neuropsychologia 40 2002 2257 2267
54. A. Dagher, A.M. Owen, H. Boecker, and D.J. Brooks The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease Brain 124 2001 1020 1032
55. J. Dalrymple-Alford, A. Kalders, R. Jones, and R. Watson A central executive deficit in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry 57 1994 360 367
56. W. Dauer, and Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
57. N. Daw, S. Kakade, and P. Dayan Opponent interactions between serotonin and dopamine Neural Networks 15 2002 603 616
58. P.B. Dews Studies on behavior. IV. Stimulant actions of methamphetamine J. Pharmacol. Exp. Ther. 1958 122
59. P.B. Dews Rate-dependency hypothesis Science 198 1977 1182 1183
60. R. Dias, T.W. Robbins, and A.C. Roberts Dissociation in prefrontal cortex of affective and attentional shifts Nature 380 1996 69 72
61. M. Dimitrov, J. Grafman, A.H.R. Soares, and K. Clark Concept formation and concept shifting in frontal lesion and Parkinson's disease patients assessed with the california card sorting test Neuropsychology 13 1999 135 143
62. I. Divac, H.E. Rosvold, and M.K. Szwarcbart Behavioral effects of selective ablation of the caudate nucleus J. Comp. Physiol. Psychol. 63 1967 184 190
63. J.J. Downes, A.C. Roberts, B.J. Sahakian, J.L. Evenden, R.G. Morris, and T.W. Robbins Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction Neuropsychologia 27 1989 1329 1343
64. J.-C. Dreher, E. Guigon, and Y. Burnod A model of prefrontal cortex dopaminergic modulation during the delayed alternation task J. Cogn. Neurosci. 14 2002 853 865
65. B. Dubois, and B. Pillon Cognitive deficits in Parkinson's disease J. Neurol. 244 1997 2 8
66. D. Durstewitz, J. Seamans, and T. Sejnowski Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex J. Neurophysiol. 83 2000 1733 1750
67. M.F. Egan, T.E. Goldberg, B.S. Kolachana, J.H. Callicott, C.M. Mazzanti, R.E. Straub, D. Goldman, and D.R. Weinberger Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc. Natl Acad. Sci. USA 98 2001 6917 6922
68. G. Everett, and J. Borcherding L-Dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice Science 168 1970 849 850
69. E. Evers, R. Cools, L. Clark, F. van der Veen, J. Jolles, B. Sahakian, and T. Robbins Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning Neuropsychopharmacology 2005 (Epub ahead of print)
70. M. Falkenstein, H. Hielscher, I. Dziobek, P. Schwarzenau, J. Hoormann, B. Sundermann, and J. Hohnsbein Action monitoring, error detection, and the basal ganglia: an ERP study NeuroReport 12 2001 157 161
71. R. Featherstone, and R. McDonald Dorsal striatum and stimulus-response learning: lesions of the dorsolateral, but not dorsomedial, striatum impair acquisition of a stimulus-response-based instrumental discrimination task, while sparing conditioned place preference learning Neuroscience 124 2004 23 31
72. L. Fellows, and M. Farah Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm Brain 126 2003 1830 1837
73. S. Floresco, A. West, B. Ash, H. Moore, and A. Grace Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission Nature Neurosci. 6 2003 968 973
74. K.A. Flowers, and C. Robertson The effect of Parkinson's disease on the ability to maintain a mental set J. Neurol. Neurosurg. Psychiatry 48 1985 517 529
75. T. Foltynie, T. Goldberg, S. Lewis, A. Blackwell, B. Kolachana, D. Weinberger, T. Robbins, and R. Barker Planning ability in Parkinson's disease is influenced by the COMT val(158)met polymorphism Mov. Disord. 19 2004 885 891
76. N. Fournet, O. Moreaud, J.L. Roulin, B. Naegele, and J. Pellat Working memory functioning in medicated Parkinson's diseas patients and the effect of withdrawal of dopaminergic medication Neuropsychology 14 2000 247 253
77. M. Frank Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and non-medicated parkinsonism J. Cogn. Neurosci. 17 2005 51 72
78. M. Frank, B. Loughry, and R. O'Reilly Interactions between frontal cortex and basal ganglia in working memory: a computational model Cogn. Affect Behav. Neurosci. 1 2001 137 160
79. M. Frank, L. Seeberger, and R. O'reilly By carrot or by stick: cognitive reinforcement learning in parkinsonism Science 306 2004 1940 1943
80. M. Fukuda, M. Ghilardi, M. Carbon, V. Dhawan, Y. Ma, A. Feigin, M. Mentis, C. Ghez, and D. Eidelberg Pallidal stimulation for parkinsonism: improved brain activation during sequence learning Ann. Neurol. 52 2002 144 152
81. J.D.E. Gabrieli, J. Singh, G.T. Stebbins, and C.G. Goetz Reduced working memory span in Parkinson's disease: evidence for the role of a frontostriatal system in working and strategic memory Neuropsychology 10 1996 322 332
82. J. Gauntlett-Gilbert, R.C. Roberts, and V.J. Brown Mechanisms underlying attentional set-shifting in Parkinson's disease Neuropsychologia 37 1999 605 616
83. C. Gerfen D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
84. W. Gibb, P. Luthert, I. Janota, and P. Lantos Cortical lewy body dementia: clinical features and classification J. Neurol. Neurosurg. Psychiatry 52 1989 185 192
85. B. Gilbert, S. Belleville, L. Bherer, and S. Chouinard Study of verbal working memory in patients with Parkinson's disease Neuropsychology 19 2005 106 114
86. I. Goerendt, A. Lawrence, and D. Brooks Reward processing in health and Parkinson's disease: neural organization and reorganization Cerebral Cortex 14 2004 73 80
87. P.S. Goldman-Rakic Cellular and circuit basis of working memory in prefrontal cortex in nonhuman primates (Review) Prog. Brain Res. 85 1990 141 153
88. P.S. Goldman-Rakic Cellular basis of working memory Neuron 14 1995 477 485
89. A. Gotham, R. Brown, and C. Marsden Levodopa treatment may benefit or impair 'frontal' function in Parkinson's disease The Lancet 2 1986 970 971
90. A.M. Gotham, R.G. Brown, and C.D. Marsden 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa Brain 111 1988 299 321
91. A.A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the ethiology of schizophrenia Neuroscience 41 1991 1 24
92. S. Granon, F. Passetti, K.L. Thomas, J.W. Dalley, B.J. Everitt, and T. Robbins Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex J. Neurosci. 20 2000 1208 1215
93. D.A. Grant, and E.A. Berg A behavioural analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card sorting problem J. Exp. Psychol. 38 1948 404 411
94. M. Grossman, G. Glosser, J. Kalmanson, J. Morris, M. Stern, and H. Hurtig Dopamine supports sentence comprehension in Parkinson's disease J. Neurol. Sci. 184 2001 123 130
95. J.H. Growdon, K. Kieburtz, M.P. McDermott, M. Panisset, J.H. Friedman, and t.P.s.S. Group Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients Neurology 50 1998 1327 1331
96. R. Halgin, M. Riklan, and H. Misiak Levodopa, parkinsonism, and recent memory J. Nerv. Ment. Dis. 164 1977 268 272
97. D.G. Harden, and A.A. Grace Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment J. Neurosci. 15 1995 6157 6166
98. C. Harmer, and G. Phillips Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine Neuroscience 90 1999 119 130
99. A.E. Hayes, M.C. Davidson, and S.W. Keele Towards a functional analysis of the basal ganglia J. Cogn. Neurosci. 10 1998 178 198
100. P. Hitchcott, C. Harmer, and G. Phillips Enhanced acquisition of discriminative approach following intra-amygdala d-amphetamine Psychopharmacology 132 1997 237 246
101. J.R. Hollerman, and A. Grace The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons Brain Res. 533 1990 203 212
102. J.R. Hollerman, and W. Schultz Dopamine neurons report an error in the temporal prediction of reward during learning Nature Neurosci. 1 1998 304 309
103. C. Holroyd, and M. Coles The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity Psychol. Rev. 109 2002 679 709
104. C. Holroyd, P. Praamstra, E. Plat, and M. Coles Spared error-related potentials in mild to moderate Parkinson's disease Neuropsychologia 40 2002 2116 2124
105. G. Honey, J. Suckling, F. Zelaya, C. Long, C. Routledge, S. Jackson, V. Ng, P. Fletcher, S. Williams, J. Brown, and E. Bullmore Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system Brain 126 2003 1767 1781
106. J. Hornak, J. O'Doherty, J. Bramham, E. Rolls, R. Morris, P. Bullock, and C. Polkey Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans J. Cogn. Neurosci. 16 2004 463 478
107. O. Hornykiewicz The mechanisms of action of l-DOPA in Parkinson's disease Life Sci. 15 1974 1249 1259
108. J. Horvitz Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events Neuroscience 96 2000 651 656
109. R. Inzelberg, M. Plotnik, T. Flash, E. Schechtman, I. Shahar, and A. Korczyn Mental and motor switching in Parkinson's disease J. Mot. Behav. 33 2001 377 385
110. R. Ito, J. Dalley, S. Howes, T. Robbins, and B. Everitt Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats J. Neurosci. 20 2000 7489 7495
111. R. Ito, J. Dalley, T. Robbins, and B. Everitt Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue J. Neurosci. 22 2002 6247 6253
112. S. Iversen, and M. Mishkin Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity Exp. Brain Res. 11 1970 376 386
113. J.D. Jentsch, P. Olausson, R. De La Garza, and J.R. Taylor Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys Neuropsychopharmacology 26 2002 183 190
114. M. Jog, Y. Kubota, C. Connolly, V. Hillegaart, and A. Graybiel Building neural representations of habits Science 286 1999 1745 1749
115. B. Jones, and M. Mishkin Limbic lesions and the problem of stimulus-reinforcement associations Exp. Neurol. 36 1972 362 377
116. V. Kaasinen, E. Nurmi, A. Bruck, O. Eskola, J. Bergman, O. Solin, and J. Rinne Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex Brain 124 2001 1125 1130
117. C. Ketcham, T. Hodgson, C. Kennard, and G. Stelmach Memory-motor transformations are impaired in Parkinson's disease Exp. Brain Res. 149 2003 30 39
118. D. Kimberg, and M. D'Esposito Cognitive effects of the dopamine receptor agonist pergolide Neuropsychologia 41 2003 1020 1027
119. D.Y. Kimberg, M. D'Esposito, and M.J. Farah Effects of bromocriptine on human subjects depend on working memory capacity NeuroReport 8 1997 3581 3585
120. S.J. Kish, K. Shannak, and O. Hornykiewicz Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease New Engl. J. Med. 318 1988 876 880
121. B.J. Knowlton, J.A. Mangels, and L.R. Squire A neostriatal habit learning-system in humans Science 273 1996 1399
122. B. Knutson, C.M. Adams, G. Fong, and D. Hommer Anticipation of increasing monetary reward selectively recruits nucleus accumbens J. Neurosci. 21 2001 1 5
123. R. Kostrzewa, P. Nowak, J. Kostrzewa, R. Kostrzewa, and R. Brus Peculiarities of l-DOPA: treatment of Parkinson's disease Amino Acids 2005 (Epub ahead of print)
124. M. Kringelbach, and E. Rolls Neural correlates of rapid reversal learning in a simple model of human social interaction NeuroImage 20 2003 1371 1383
125. J. Kulisevsky Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease Drugs Aging 16 2000 365 379
126. J. Kulisevsky, A. Avila, M. Barbano, R. Antonijoan, M.L. Berthier, and A. Gironell Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels Brain 119 1996 2121 2132
127. J. Kulisevsky, D. Lopez-Villegas, C. Garcia-Sanchez, M. Barbanoj, A. Gironell, and B. Pascual-Sedano A six-month study of pergolide and levodopa in de novo Parkinson's disease patients Clin. Neuropharmacol. 21 1998 358 362
128. K.W. Lange, T.W. Robbins, C.D. Marsden, M. James, A.M. Owen, and G.M. Paul l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction Psychopharmacology 107 1992 394 404
129. A. Lawrence, A. Evans, and A. Lees Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? The Lancet 2 2003 595 604
130. A.J. Lees, and E. Smith Cognitive deficits in the early stages of Parkinson's disease Brain 106 1983 257 270
131. R. Levy, H. Friedman, L. Davachi, and P. Goldman-Rakic Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks J. Neurosci. 17 1997 3870 3882
132. D. Lewis, D. Melchitzky, S. Sesack, R. Whitehead, S. Auh, and A. Sampson Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization J. Comp. Neurol. Psychol. 432 2001 119 136
133. S. Lewis, R. Cools, T. Robbins, A. Dove, R. Barker, and A. Owen Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease Neuropsychologia 41 2003 645 654
134. S. Lewis, A. Dove, T. Robbins, R. Barker, and A. Owen Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry J. Neurosci. 23 2003 6351 6356
135. S. Lewis, A. Dove, T. Robbins, R. Barker, and A. Owen Striatal contributions to working memory: a functional magnetic resonance imaging study in humans Eur. J. Neurosci. 19 2004 755 760
136. S. Lewis, A. Slabosz, T. Robbins, R. Barker, and A. Owen Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease Neuropsychologia 43 2005 823 832
137. K. Lloyd, L. Davisdson, and O. Hornykiewicz The neurochemistry of Parkinson's disease: effect of l-DOPA therapy J. Pharmacol. Exp. Ther. 195 1975 229 233
138. N. Mackintosh A theory of attention: variations in the associability of stimulus with reinforcement Psychol. Rev. 82 1975 276 298
139. C. Malapani, B. Pillon, B. Dubois, and Y. Agid Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction Neurology 44 1994 319 326
140. A.K. Malhotra, L.J. Kestler, C.M. Mazzanti, J.A. Bates, T.E. Goldberg, and D. Goldman A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition Am. J. Psychiatry 159 2002 652 654
141. R.M. Marie, B. Dupuy, F. Viader, G. Defer, and J.C. Baron Relationship between striatal dopamine denervation and frontal executive tests in Parkinson's disease Neurosci. Lett. 260 1999 77 80
142. W. Maruyama, M. Naoi, and H. Narabayashi The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients J. Neurol. Sci. 139 1996 141 148
143. V.S. Mattay, A. Tessitore, J.H. Callicott, A. Bertonlino, T.E. Goldberg, T.N. Chase, T.M. Hyde, and D.R. Weinberger Dopaminergic modulation of cortical function in patients with Parkinson's disease Ann. Neurol. 58 2002 630 635
144. 158 -met genotype and individual variation in the brain response to amphetamine Proc. Natl Acad. Sci. USA 100 2003 6186 6191
145. S. McClure, G. Berns, and P. Montague Temporal prediction errors in a passive learning task activate human striatum Neuron 38 2003 339 346
146. R. McDonald, and N. White A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum Behav. Neurosci. 107 1993 3 22
147. S. McDowell, J. Whyte, and M. D'Esposito Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients Brain 121 1998 1155 1164
148. M. Mehta, A.M. Owen, B.J. Sahakian, N. Mavaddat, J.D. Pickard, and T.W. Robbins Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain J. Neurosci. 2000 1 6
149. M.A. Mehta, R. Swainson, A.D. Ogilvie, B.J. Sahakian, and T.W. Robbins Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers Psychopharmacology 159 2001 10 20
150. M. Mehta, S. McGowan, A. Lawrence, M. Aitken, A. Montgomery, and P. Grasby Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning NeuroImage 20 2003 1982 1994
151. M. Mehta, M. Goodyer, and B. Sahakian Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity J. Child Psychol. Psychiatry 45 2004 293 305
152. M. Mehta, F. Manes, G. Magnolfi, B. Sahakian, and T. Robbins Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers Psychopharmacology 2004 (Epub ahead of print)
153. N. Meiran, G. Friedman, and E. Yehene Parkinson's disease is associated with goal setting deficits during task switching Brain Cogn. 54 2004 260 262
154. Meyer, D.E., Evans, J.E., Lauber, E.J., Gmeindl, L., Rubinstein, J., Junck, L., Koeppe, R.A., 1998. The role of dorsolateral prefrontal cortex for executive cognitive processes in task switching. Annual Meeting of the Cognitive Neuroscience Society, San Francisco, CA.
155. F.A. Middleton, and P.L. Strick The temporal lobe is a target of output from the basal ganglia Proc. Natl Acad. Sci. 93 1996 8683 8687
156. M.J. Millan, A. Dekeyne, and A. Gobert Serotonin (5-HT) 2c receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but ont 5-HT, release in the frontal cortex in vivo Neuropharmacology 37 1998 953 955
157. D. Miller, and E. Abercrombie Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous l-DOPA: studies in intact and 6-hydroxydopamine- treated rats J. Neurochem. 72 1999 1516 1522
158. E. Miller, C. Erikson, and R. Desimone Neural mechanisms of visual working memory in prefrontal cortex of the macaque J. Neurosci. 16 1996 5154 5167
159. E. Mohr, G. Fabbrini, S. Ruggieri, P. Fedio, and T. Chase Cognitive concomitants of dopamine system stimulation in parkinsonian patients J. Neurol. Neurosurg. Psychiatry 50 1987 1192 1196
160. H. Mollion, J. Ventre-Dominey, P.F. Dominey, and E. Broussolle Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease Neuropsychologia 41 2003 1442 1451
161. I. Monchi, M. Petrides, J. Doyon, R. Postuma, K. Worsley, and A. Dagher Neural bases of set-shifting deficits in Parkinson's disease J. Neurosci. 24 2004 702 710
162. R.G. Morris, J.J. Downes, B.J. Sahakian, J.L. Evenden, A. Heald, and T.W. Robbins Planning and spatial working memory in Parkinson's disease J. Neurol. Neurosurg. Psychiatry 51 1988 757 766
163. C. Morrison, J. Borod, K. Perrine, A. Beric, M. Brin, A. Rezai, P. Kelly, D. Sterio, I. Germano, D. Weisz, and C. Olanow Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease Arch. Clin. Neuropsychol. 19 2004 165 181
164. U. Muller, T. Wachter, H. Barthel, M. Reuter, and D.Y. von Cramon Striatal [123]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease J. Neural Transm. 107 2000 303 319
165. Y. Nagahama, T. Okada, Y. Katsumi, T. Hayashi, H. Yamauchi, C. Oyanagi, J. Konishi, H. Fukuyama, and H. Shibasaki Dissociable mechanisms of attentional control within the human prefrontal cortex Cerebral Cortex 11 2001 85 92
166. S. Nicholson, and J. Brotchie 5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapteuric to redu the problems of levodopa therapy Eur. J. Neurol. 9 2002 1 6
167. S. Nieuwenhuis, C. Holroyd, N. Mol, and M. Coles Reinforcement-related brain potentials from medial frontal cortex: origins and functional significance Neurosci. Biobehav. Rev. 28 2004 441 448
168. 158Met polymorphism in schizophrenia: differential effects of val and met alleles on cognitive stability and flexibility Am. J. Psychiatry 161 2004 359 361
169. J.A. Obeso, M.C. Rodriguez-Oroz, J.L. Lanciego, J. Artieda, N. Gonzalo, and C.W. Olanow Pathophysiology of the basal ganglia in Parkinson's disease Trends Neurosci. 23 2000 S8 S19
170. J. O'Doherty, M. Kringelbach, E. Rolls, J. Hornak, and C. Andrews Abstract reward and punishment representations in the human orbitofrontal cortex Nature Neurosci. 4 2001 95 102
171. J. O'Doherty, H. Critchley, R. Deichmann, and R.J. Dolan Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices J. Neurosci. 23 2003 7931 7939
172. J. O'Doherty, P. Dayan, K. Friston, H. Critchley, and R. Dolan Temporal difference models and reward-related learning in the human brain Neuron 38 2003 329 337
173. J. O'Doherty, P. Dayan, J. Schultz, R. Deichmann, K. Friston, and R. Dolan Dissociable role of ventral and dorsal striatum in instrumental conditioning Science 304 2004 452 454
174. R. O'Reilly, D. Noelle, T. Braver, and J. Cohen Prefrontal cortex and dynamic categorization tasks: representational organization and neuromodulatory control Cerebral Cortex 12 2002 246 257
175. A. Owen Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry The Neuroscientist 10 2004 525 535
176. A.M. Owen, M. James, J.M. Leigh, B.A. Summers, C.D. Marsden, N.P. Quinn, K.W. Lange, and T.W. Robbins Fronto-striatal cognitive deficits at different stages of Parkinson's disease Brain 115 1992 1727 1751
177. A.M. Owen, A.C. Roberts, J.R. Hodges, B.A. Summers, C.E. Polkey, and T.W. Robbins Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease Brain 116 1993 1159 1179
178. A.M. Owen, B.J. Sahakian, J.R. Hodges, B.A. Summers, C.E. Polkey, and T.W. Robbins Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease Neuropsychology 9 1995 126 140
179. A.M. Owen, J. Doyon, A. Dagher, A. Sadikot, and A.C. Evans Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions Brain 121 1998 949 965
180. M. Packard, and N. White Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists Behav. Neurosci. 105 1991 295 306
181. G. Pagnoni, C. Zink, P. Montague, and G. Berns Activity in human ventral striatum locked to errors of reward prediction Nature Neurosci. 5 2002 97 98
182. A.M. Paolo, A.I. Troster, B. Axelrod, and W.C. Koller Construct validity of the WCST in normal elderly and persons with Parkinson's disease Arch. Clin. Neuropsychol. 10 1995 463 473
183. S. Park, J. Coull, R. McShane, A. Young, B. Sahakian, T. Robbins, and P. Cowen Tryptophan depletion in normal volunteers produces selective impairments in learning and memory Neuropharmacology 33 1994 575 588
184. A. Partiot, M. Verin, B. Pillon, C. Teixeira-Ferreira, Y. Agid, and B. Dubois Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation Neuropsychologia 34 1996 709 721
185. W. Paulus, and K. Jellinger The neuropathological basis of different clinical subgroups of Parkinson's disease J. Neuropathol. Exp. Neurol. 50 1991 743 755
186. A. Phillips, S. Ahn, and S. Floresco Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task J. Neurosci. 14 2004 547 553
187. M. Pilla, S. Perachon, F. Sautel, F. Garrido, A. Mann, C. Wermuth, J. Schwartz, B. Everitt, and P. Sokoloff Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 400 1999 371 375
188. B. Pillon, B. Deweer, M. Vidailhet, A. Bonnet, V. Hahn-Barma, and B. Dubois Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes Neuropsychologia 36 1998 1 9
189. B. Pillon, V. Czernecki, and B. Dubois Dopamine and cognitive function Curr. Opin. Neurobiol. 16 2003 S1 S6
190. W. Poewe, W. Berger, T. Benke, and L. Schelosky High-speed memory scanning in Parkinson's disease: adverse effects of levodopa Ann. Neurol. 29 1991 670 673
191. P. Pollux Advance preparation of set-switches in Parkinson's disease Neuropsychologia 42 2004 912 919
192. P. Pollux, and C. Robertson Reduced task-set inertia in Parkinson's disease J. Clin. Exp. Neuropsychol. 24 2002 1046 1056
193. P. Praamstra, D. Stegeman, A. Cools, and M. Horstink Reliance on external cues for movement initiation in Parkinson's disease. Evidence from movement-related potentials Brain 121 1998 167 177
194. J. Rakshi, T. Uema, K. Ito, D. Bailey, P. Morrish, J. Ashburner, A. Dagher, I. Jenkins, K. Friston, and D. Brooks Frontal, midbrain and striatal dopamergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study Brain 1999 122
195. S. Ravizza, and M. Ciranni Contributions of the prefrontal cortex and basal ganglia to set shifting J. Cogn. Neurosci. 14 2002 472 483
196. P.J. Reading, B. Dunnett, and T.W. Robbins Dissociable roles of the ventral, medial and lateral striatum on the acquisition and performance of a complex visual stimulus-response habit Behav. Brain Res. 45 1991 147 161
197. P. Redgrave, T.J. Prescott, and K. Gurney Is the short-latency dopamine response too short to signal reward error Trends Neurosci. 22 1999 146 151
198. R.M. Ridley, T.A. Haystead, and H.F. Baker An analysis of object reversal learning in the marmoset after amphetamine and haloperidol Pharmacol. Biochem. Behav. 14 1981 345 351
199. M. Riekkinen, K. Kejonen, P. Jakala, H. Soininen, and P. Riekkinen Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson's disease Eur. J. Neurosci. 10 1998 1429 1435
200. J.O. Rinne, R. Portin, H. Ruottinen, E. Nurmi, J. Bergman, M. Haaparanta, and O. Solin Cognitive impairment and the brain dopaminergic system in Parkinson's disease Arch. Neurol. 57 2000 470 475
201. T.W. Robbins Chemical neuromodulation of frontal-executive functions in humans and other animals Exp. Brain Res. 133 2000 130 138
202. T.W. Robbins, and B.J. Everitt Functions of dopamine in the dorsal and ventral striatum Semin. Neurosci. 4 1992 119 127
203. T.W. Robbins, and B.J. Sahakian 'Paradoxical' effects of psychomotor stimulant drugs in hyperactive children from the standpoint fo behavioural pharmacology Neuropharmacology 18 1979 931 950
204. T.W. Robbins, M. Cador, J.R. Taylor, and B.J. Everitt Limbic-striatal interactions in reward-related processes Neurosci. Biobehav. Rev. 13 1989 155 162
205. A.C. Roberts, and J.D. Wallis Inhibitory control and affecttive processing in the prefrontal cortex Cerebral Cortex 10 2000 252 262
206. A.C. Roberts, T.W. Robbins, and B.J. Everitt The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates Q. J. Exp. Psychol. 40b 1988 321 341
207. A.C. Roberts, M.A. De Salvia, L.S. Wilkinson, P. Collins, J.L. Muir, B.J. Everitt, and T.W. Robbins 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the wisconsin card sort test: possible interactions with subcortical dopamine J. Neurosci. 14 1994 2531 2544
208. R.D. Rogers, and S. Monsell Costs of a predictable switch between simple cognitive tasks J. Exp. Psychol. 124 1995 207 231
209. R.D. Rogers, B.J. Sahakian, J.R. Hodges, C.E. Polkey, C. Kennard, and T.W. Robbins Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease Brain 121 1998 815 842
210. R.D. Rogers, A.M. Owen, H.C. Middleton, E.J. Williams, J.D. Pickard, B.J. Sahakian, and T.W. Robbins Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbitofrontal cortex J. Neurosci. 20 1999 9029 9038
211. R.D. Rogers, T.C. Andrews, P.M. Grasby, D.J. Brooks, and T.W. Robbins Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans J. Cogn. Neurosci. 12 2000 142 162
212. J. Rowe, K. Stephan, K. Friston, R. Frackowiak, A. Lees, and R. Passingham Attention to action in Parkinson's disease. Impaired effective connectivity among frontal cortical regions Brain 125 2002 276 289
213. T. Sawaguchi, M. Matsumura, and K. Kubota Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex J. Neurophysiol. 63 1990 1385 1399
214. A. Schrag, M. Jahanshahi, and N. Quinn What contributes to quality of life in patients with Parkinson's disease? J. Neurol. Neurosurg. Psychiatry 69 2000 308 312
215. W. Schultz Multiple reward signals in the brain Nature Rev. Neurosci. 1 2000 199 207
216. W. Schultz, and A. Dickinson Neuronal coding of prediction errors Annu. Rev. Neurosci. 23 2000 473 500
217. J. Seamans, D. Durstewitz, B. Christie, C. Stevens, and T. Sejnowski Dopamine D1/D5 receptor modulation of excitatory synaptic input to layer V prefrontal cortex neurons Proc. Natl Acad. Sci. USA 98 2001 301 306
218. J. Seamans, N. Gorelova, D. Durstewitz, and C. Yang Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons J. Neurosci. 21 2001 3628 3638
219. L. Selemon, and P. Goldman-Rakic Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey J. Neurosci. 5 1985 776 794
220. D. Shohamy, C. Myers, S. Grossman, J. Sage, and M. Gluck The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease Behav. Brain Res. 156 2 2005 191 199
221. J. Smiley, A. Levey, B. Ciliax, and P. Goldman-Rakic Free in PMC D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines Proc. Natl Acad. Sci. USA 91 1994 5720 5724
222. A. Smith, J. Neill, and B. Costall The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset Pharmacol. Biochem. Behav. 63 1999 201 211
223. M. Sohn, S. Ursu, J.R. Anderson, V.A. Stenger, and C.S. Carter The role of prefrontal cortex and posterior parietal cortex in task switching Proc. Natl Acad. Sci. USA 97 2000 13448 13453
224. G. Stebbins, J. Gabrieli, F. Masciari, L. Monti, and C. Goetz Delayed recognition memory in Parkinson's disease: a role for working memory? Neuropsychologia 37 1999 503 510
225. C. Stern, and R. Passingham The nucleus accumbens in monkeys (macaca fascicularis) Exp. Brain Res. 106 1995 239 247
226. R. Swainson, R.D. Rogers, B.J. Sahakian, B.A. Summers, C.E. Polkey, and T.W. Robbins Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication Neuropsychologia 38 2000 596 612
227. K. Taghzouti, A. Louilot, J. Herman, M. Le Moal, and H. Simon Alternation behaviour, spatial discrimination, and reversal disturbances following 6-Hydroxydopamine lesions in the nucleus accumbens of the rat Behav. Neural. Biol. 44 1985 354 363
228. J. Taylor, and T. Robbins Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens Psychopharmacology 84 1984 405 412
229. A. Taylor, and J. Saint-Cyr The neuropsychology of Parkinson's disease Brain Cogn. 28 1995 281 296
230. A.E. Taylor, J.A. Saint-Cyr, and A.E. Lang Frontal lobe dysfunction in Parkinson's disease Brain 109 1986 845 883
231. A. Thiel, R. Hilker, J. Kessler, B. Habedank, K. Herholz, and W. Heiss Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study J. Neural. Transm. 110 2003 1289 1301
232. E. Tricomi, M. Delgado, and J. Fiez Modulation of caudate activity by action contingency Neuron 41 2004 281 292
233. D. van der Kooy, N. Swerdlow, and G. Koob Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions Brain Res. 259 1983 111 118
234. K. Van Spaendonck, H. Berger, M. Horstink, E. Buytenhuijs, and A. Cools Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy Neuropsychologia 31 1993 407 411
235. K.P.M. Van Spaendonck, H.J.C. Berger, M.W.I. Horstink, G.F. Borm, and A.R. Cools Card sorting performance in Parkinson's disease: a comparison between acquisition and shifting performance J. Clin. Exp. Neuropsychol. 17 1995 918 925
236. P. Voorn, L. Vanderschuren, H. Groenewegen, T. Robbins, and C. Pennartz Putting a spin on the dorsal-ventral divide of the striatum Trends Neurosci. 27 2004 468 474
237. P. Waelti, A. Dickinson, and W. Schultz Dopamine responses comply with basic assumptions of formal learning theory Nature 412 2001 43 48
238. Y. Wang, and P. Goldman-Rakic D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons Proc. Natl Acad. Sci. USA 101 2004 5093 5098
239. C. Whittington, J. Podd, and M. Kan Recognition memory impairment in Parkinson's disease: power and meta-analyses Neuropsychology 14 2000 233 246
240. J. Wilder Recent developments in the law of initial values Exp. Med. Surg. 20 1962 126 131
241. G.V. Williams, and P.S. Goldman-Rakic Modulation of memory fields by dopamine D1 receptors in prefrontal cortex Nature 376 1995 572 575
242. S. Woods, and A. Troster Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease J. Int. Neuropsychol. Soc. 9 2003 17 24
243. T. Woodward, D. Bub, and M. Hunter Task switching deficits associated with Parkinson's disease reflect depleted attentional resources Neuropsychologia 40 2002 1948 1955
244. C. Wyvell, and K. Berridge Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward 'wanting' without enhanced 'liking' or response reinforcement J. Neurosci. 20 2000 8122 8130
245. H. Yin, B. Knowlton, and B. Balleine Lesion of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning Eur. J. Neurosci. 19 2004 181 189
246. J. Zahrt, J.R. Taylor, R.G. Mathew, and A.F.T. Arnsten Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance J. Neurosci. 17 1997 8528 8535
247. D. Zald, C. Curtis, B. Folley, and J. Pardo Prefrontal contributions to delayed spatial and object alternation: a positron emission tomography study Neuropsychology 16 2002 182 189